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SUMMARY
Background. Creutzfeldt-Jakob Disease (CJD) is a degenerative disease of the brain, characterized by rapid and
irreversible decline, with dementia, ataxia, myoclonus, and other neurological and neurobehavioral disorders
associated with rapidly progressive spongiform encephalopathy. The mode of transmission and basic
pathomechanism remain unclear. The clinical picture of CJD is highly diverse, producing a number of variants.
Material and methods. The patient to be described is a 68-year-old Polish female, JR, clinically diagnosed with
CJD. The article presents the case history in detail, with particular emphasis on neuropsychological testing,
which was initiated when the patient was still lucid and capable of cooperation. The first presenting symptom
was agraphia, followed by hemianopsia and other vision disorders, culminating in visual hallucinations. As the
progress of the disease accelerated there was rapidly progressive dementia, aphasia developing to organic
mutism, myoclonus, hyperkinesia, ultimately loss of all verbal contact or voluntary movement. 
Results. JR’s neuropsychological parameters declined in a period of less than 3 months from near normal to
levels characteristic of severe dementia.
Conclusions. The clinical picture here presented is consistent with that of the Heidenhain variant of CJD, with
spongiform encephalopathy beginning in the right occipital lobe. Several features of the case remain atypical,
however, including the absence of the most common genetic mutation and the patient’s long survival after onset.
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BACKGROUND
Spongiform encephalopathy (SE) in various forms
occurs in many degenerative diseases of the central
nervous system, including Alzheimer’s Disease, a
number of mitochondrial cytopathies [1], and the
prion diseases that have recently been attracting so
much attention in Europe and elsewhere [2,3]. The
name is derived from the prominent vacuolation of
the gray matter of the brain, producing a
‘spongelike’ appearance on light microscopy [4]. 
The clinical symptoms associated with SE are
typically of insidious onset, due to the cumulative
effect of neuronal loss without organized areas of
necrosis visible in normal neuroimaging scans [5,6].
Complex cerebral functions involving the
cooperation of numerous neural centers and
pathways [7] are naturally the most vulnerable to
this kind of damage, which explains why the
leading symptom is typically dementia, sometimes
preceded, followed, or accompanied by a variety
of other neurological and neurobehavioral
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disturbances, including ataxia, myoclonic seizures,
and psychosis. For reasons that remain unclear, the
degenerative process associated with SE typically
begins at a particular point in the brain and spreads
outward [4,8,9], so that the nature and course of
the CNS symptoms associated with SE seem to be
related to the initial point of attack and the rate of
dissemination [8,10]. 
Of the various diseases caused by or causing spon-
giform encephalopathy, the prion diseases are per-
haps the most interesting, and surely the most con-
troversial. A prion is a transmissible pathogen that
is neither a bacterium nor a virus, but rather a pro-
tein (PrP), lacking any replicative elements. The
term was coined by Stanley Prusiner [11], whose
discovery of prions won him the Nobel Prize for
medicine in 1997. The PrP protein is genetically
coded by the PRNP gene in the human chromoso-
me. It occurs primarily in the central nervous sys-
tem, but its exact function remains unknown
[12–14]. Pathogenic prions (PrPSc) are biochemi-
cally configured in such a way that they attach to
normal PrP molecules (PrPC) and transform them
into the PrPSc configuration, which differs from
PrPC in its almost complete lack of susceptibility to
protease [4,15]; the proliferation of PrPSc leads to
cell death and SE, though exactly how and why
this occurs remains unclear.
Apart from the various known animal diseases
known or thought to be linked to prions (including
especially bovine spongiform encephalopathy,
BSE), there exists also an entire array of phenotypi-
cally distinct human prion diseases [16], varying in
course and (probable) mode of transmission, of
which the most notorious is Creutzfeldt-Jakob Di-
sease (CJD), characterized by rapidly progressive
severe dementia, ataxia, myoclonus, and hyperki-
nesia. CJD typically has a very long incubation pe-
riod (up to 20 years [4]), but after the first clinical
symptoms appear the patient enters into an irrever-
sible rapid decline, ending in death.
Several variants of CJD have thus far been identi-
fied:
– sporadic (sCJD), occurring in patients older than
60, the form originally identified by Creutzfeldt
[17] and Jakob [18];
– familial (fCJD), a genetically transmitted form
[19,20];
– iatrogenic (iCJD), mostly traceable to neurosur-
gical procedures [21,22] or injections of human
growth factor [23,24,25], or various kinds of hor-
mones from untested sources [26,27];
– new variant (nvCJD), which appears to be a
transmissible human form of bovine spongiform
encephalopathy (BSE), the famous ‘mad cow’
disease [28,29];
– the Heidenhain variant (HvCJD), probably a form
of sCJD in which vision disturbances are the first
presenting symptoms [30,31].
As in the case of Alzheimer’s Disease, the diagnosis
of CJD cannot be definitively established until
neuropathological autopsy results have revealed
the characteristic findings (esp. SE, amyloid plaques
without the characteristic neurofibrillary tangles of
Alzheimer’s Disease, etc.). The presence of protein
14-3-3 in cerebro-spinal fluid is fairly specific for
CJD, with some differences among the variants
[32]; for example, all published cases of HvCJD to
date have been positive for 14-3-3 in the CSF [33].
EEG results show certain characteristic features
[34], especially periodic or pseudoperiodic
paroxysms of triphasic or sharp waves of 0.5 to 2.0
Hz against a slow background [4,35]. Functional
imaging technologies (PET, SPECT) that reveal
areas of metabolic abnormality in the brain have
also proved to be useful in detecting early signs of
CJD, when MRI and CT images are normal or at
least non-specific [5,10,36].
CASE REPORT
The patient to be described here is a 68-year-old
right-handed Polish female, initials JR. She is
presently widowed (her husband died of lung
cancer in 1990), with children and grandchildren,
all healthy. There is no family history of
neurological illnesses (migraine, stroke,
neuropathy, AD, MS, etc.), and her previous
medical history is unremarkable (overweight, mild
hypertension controlled by medication, instability
of cervical spine, no surgical operations, no
hospitalizations apart from childbirth). The family
reports that she was never particularly fond of
meat dishes and especially disliked beef. As a
young woman, however, she worked in a factory
that manufactured animal hair brushes for export,
so she had contact with animal byproducts
(including bovine) and chemical agents of various
kinds. Her only foreign travel was a trip to Kiev in
1986, shortly after the Chernobyl explosion. As
far as can be ascertained, she was never
subjected to hormone therapy, neurosurgery, or
other medical procedures known to be risk
factors for iCJD.
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Disquieting events that in retrospect may be
related to the onset of CJD began in early 2000. In
March, after a short walk uphill, she suddenly
began to sweat profusely, from the head only,
though she was not especially fatigued. The
sweating subsided within a few minutes and she
did not seek medical attention. In June, she was
bitten by an insect, probably a mosquito, and
developed an abscess, which required outpatient
surgery and antibiotics; later, however, she
developed severe edema involving the entire left
side of her face, though there was no previous
history of drug allergy. The family also reports in
retrospect that during the summer of 2000 some
negative changes took place in her personality. She
had always been a warm and kind woman, much
beloved in the family, but during this period she
began to be uncharacteristically short-tempered
and quarrelsome. She also noticeably lost interest
in previous avocations and pastimes.
An examination of her monthly payment book for
her apartment shows signs of a sudden change in
July (cf. Fig. 1). All earlier entries are uniform in
character, legible, and completely routine. In the
June entry the letters are slightly larger than usual,
but the content is unchanged. In the July entry,
however, there are several features that attract
notice. To begin with, she has misspelled
(telescoped) the word ‘seventy’, a mistake not
made on any previous form. On the reverse, JR has
written a calculation of the amount due that
month, which also does not occur in any previous
month; the family states that she had always been
proud of her ability to do arithmetical problems in
her head. The notation on the reverse is
disorganized, and the phrase ‘for the year 1999’ at
the bottom is highly problematic: she seems to
have written the letter ‘r’ (Polish abbreviation for
‘year’) twice, then corrected the first ‘r’ to a 6,
which in context is completely unmotivated. The
next month, the problems are even more
apparent: on the obverse, her signature is in the
wrong place and is clearly altered from the
previous pattern. This time there are even more
mistakes in the sum written out, so that the postal
clerk was reluctant to accept the payment. On the
reverse, she first wrote ‘July’ (Polish ‘lipiec’), and
then corrected to ‘August’ (sierpieƒ) by simply
writing over. The year is given as ‘20000’
(perseveration), and instead of the standard
abbreviation ‘r’ she has written out the word ‘rok’
(‘year’), though it is barely legible. In September,
after yet another quarrel with the postal clerk, she
asked her son to help her fill out the forms, and
from that point on she gradually ceased to take
care of her own affairs.
The family was concerned, but attributed the
changes to advancing age and stress. Medical
attention was not sought until mid-September,
when she began to experience vision disorders and
reported to an ophthalmologist. Her initial
complaint was that objects in the immediate
vicinity would suddenly seem to be much closer,
or sometimes much farther away, than in fact they
were. An opthalmological examination showed
hemianopsia, unaccompanied by pyramidal
symptoms. By early October JR had lost all sense of
visual perspective, and the visual images also
began to be seriously distorted. She first reported




that automobiles on the street looked very flat;
later, she commented with consternation that her
daughter’s face was horribly distorted, virtually
repulsive, with all the features out of place. She
also manifested hypersensitivity to bright colors,
especially red, which she avoided (during this
period she discarded all her red towels and
replaced them with dark blue). In early November
a test of her field of vision showed restrictions (cf.
Fig. 2), though the hemianopsia had momentarily
receded, only to return several weeks later. Her
gait had slowed considerably, but she herself
attributed this to her difficulties in maintaining
visual perspective and anxiety that she would
stumble over something. Later, she complained of
a feeling that a great precipice was opening before
her feet, and if she took one more step forward she
would fall into a chasm.
Systematic neuropsychological testing began in early
October [37]. The patient did not have aphasia at
this point, as shown by a normal score on the
Western Aphasia Battery - Revised (WAB-R) [38]. It
was noticed, however, that she showed hesitation in
some naming tasks, and in ordinary conversation
complained of being occasionally unable to recall
words; this was reflected in a low-normal score on
the Boston Naming Test (BNT) [39]. She had
difficulties with simple arithmetical operations and
was unable to complete all but the very simplest
block pattern tests in the Wechsler Adult Intelligence
Scale - Revised [40]. Delayed verbal and visual recall
were below normal for her age group on the
Wechsler Memory Scale - Revised (WMS-R) [41].
On selected subtests from the Cracow Right
Hemisphere Diagnostic Battery [42] her scores were
somewhat below normal in the areas of agnosia,
constructive apraxia, and apragmatism, but not in
the range typical for patients with RH strokes. Tests
for hemispatial neglect showed a slight tendency to
neglect the left side, which on repeated tests
became much more pronounced.
By this time she had begun to have hallucinations.
In early October she reported seeing black spots
before her eyes; by late October the black spots
had become insects climbing the walls. She was
still aware that these were indeed hallucinations; at
times she even joked about them.
In mid-November, in view of worsening problems
with her gait and increasing difficulties in coping
with daily living she was hospitalized in the
Department of Neurology at the Ministerial
Hospital of the Polish Ministry of Internal Affairs
and Administration (MSWiA) in Cracow. Except for
a brief furlough during the Christmas holidays she
has been confined to hospital since that time,
under the care of the second author of the present
article. Her difficulties with naming increased, and
she was observed to have growing difficulties with
pragmatics: inability to maintain the topic of
conversation, violations of turn-taking rules, etc.
The family, nursing staff and JR’s fellow patients
reported an increasing tendency to monologizing.
Repeated neuropsychological testing showed
declines in virtually all measured parameters,
including perseveration (cf. Fig. 3).
Figure 2. JR’s field of vision (November 2, 2000); a) left eye, b) right eye.
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An MRI performed after admission showed Virchov
perivascular spaces in the vicinity of the medial
section of the putamen (on the right side and
posterior left), isolated minor hyperintensive foci
visible in T2 and FLAIR sequences in the vicinity of
the corona radiata bilaterally, and cortical and
subcortical cerebral atrophy (esp. the left and right
insula, parahippocampal gyrus, and frontal region).
By mid-December JR ceased to be critical of her
hallucinations. During this period she showed for
the first time a pathological score on the WAB-R,
and verbal contact with the examiners began to be
difficult. When actively hallucinating she was
disoriented and unresponsive. In view of the rapid
deterioration the decision was made to test the
patient for possible CJD, and a sample of her CSF
was sent to a German laboratory to test for the
presence of the 14-3-3 marker protein. An EEG
performed at this time revealed periodic triphasic
sharp waves, particularly in the occipital lobes, and
myoclonus occurring synchronically with
generalized periodic epileptiform discharges. Viral
encephalitis was definitively excluded by
laboratory tests for cytomegalovirus and other
encephalitic agents. When the results of the test for
14-3-3 were returned positive, the patient received
a clinical diagnosis of CJD, pending neuropatho-
logical confirmation of SE.
The tempo of mental and physical deterioration
began to accelerate rapidly in mid-December.
Neuropsychological testing was possible for the
last time just before the Christmas holidays. By
this time the patient was bedridden with severe
left hemiparesis; visually she reacted only to
large, red objects, so the authors adapted a
number of tests accordingly to enable her to
complete the tasks. She recognized and correctly
identified some of the large red cut-out figures,
though her verbal output was now scarce and
barely audible. When asked to point to specified
geometrical figures she was able to comply,
though in order to look at the test cards she
turned her head sharply to the right and rotated
her eyes sharply to the left. She showed severe
left-sided neglect in a large-figure (10 cm x 10
cm) cancellation task, which is also apparent in
the drawings she made at that time (Fig. 4), at a
point when she was still able to hold the pen.
Figure 3. Perseveration test (instruction: “Please make five exact
copies of the model figure”), mid-November 2000.
Figure 4. Three drawings made by JR on December 23, 2000, showing hemispatial neglect and constructive apraxia; a) house; b) tree; c) person
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In mid-January an effort was made to repeat the MRI
examination, but only a few images could be made
due to the patient’s restlessness and inability to
cooperate; nothing remarkable was found. On this
occasion the authors were able to evoke no more
than three or four words in simple repetition, and by
the next day she ceased to speak entirely. For the
next few days she was minimally and sporadically
responsive to simple verbal commands, but within a
week she ceased to show any signs of awareness.
Myoclonus and hyperkinesia appeared, and became
steadily more intense. JR reacted to sudden noises by
slowly raising her right arm after a 1-5 second delay.
At such times she often displayed a catatonic
reaction: the arm would remain in the position she
left it, or in the position given by the therapist, until
moved by some outside force. She had sleep-wake
cycles and often held her eyes open during the day,
but did not follow movements or show any sign of
voluntary eyeball movement; rather, her eyes moved
in a repetitive symmetric jerking rhythm upwards
and to the left. A specialized ophthalmological
examination showed cortical blindness with no signs
of remarkable ocular pathology. 
In view of the typical progress of the disease and
the high probability that the diagnosis was
accurate, there was a general expectation that
death would ensue within the next few days or
weeks. However, JR has remained stable in her
present condition since that time, with no
significant changes. The hyperkinesia and
myoclonus have receded, but not completely
disappeared. The jerking eye movements have also
ceased, but there is no voluntary eye movement.
JR must now be fed by nasogastric tube, since the
swallowing reflex has disappeared. Infections have
developed on several occasions, but so far, despite
her weakened condition, the organism has
successfully rallied to defend itself. Occasionally
when she is spoken to by her son or daughter tears
appear in her eyes, but there is no other reaction
to any stimulus or sign of awareness of the
environment.
A DNA sample isolated from JR’s blood has been
tested genetically at the University of California at
San Francisco under the supervision of S. Prusiner.
To date it has been discovered that the most
common mutation associated with CJD, at codon
129, is not present. Further testing is in progress.
RESULTS
Table 1 gives the results of three successive
administrations of the neuropsychological tests
given to JR during her illness; in order to illustrate
the trends graphically, the results for the WAIS-R
have also been presented in the form of a graph
(see Fig. 5). 
Test Scale
Examination
early October mid-November late December











































































Table 1. Results of standard neuropsychological tests in October, November, and December, 2000.
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The decline in all parameters in all tests is
dramatic, and also very nearly parallel. The
tendency to lower scores on those elements of the
tests that involve visual processing points not only
to the effects of the reported visual problems, but
even more particularly to disturbances affecting the
right hemisphere first. Nevertheless, the declines in
left-hemisphere functions (especially verbal) lag
only slightly behind. These findings are generally
consistent with the EEG results, pointing to the
right occipital as the point of attack. The rate of
decline is much faster and sharper than typical in
cases of progressive dementia, such as dementia of
the Alzheimer’s type.
DISCUSSION
There are a number of atypical features in the case
reported here. In the literature on CJD, though there
are several reports of aphasia as an initial presenting
symptom of CJD [43], there is no previous mention
of agraphia, which in JR’s case appears in retrospect
to have been the first explicit neurological symptom.
A careful examination of Fig. 1 will reveal that JR’s
difficulties with writing are not simply the result of
distorted vision; in this context the co-occurring
perseveration and disorganization are especially
revealing. Writing requires both a visual and motor
image of the letters to be formed [44], and is thus
somewhat more dependent on right-hemisphere
functions than is speech.
It emerges rather clearly from the data and history
presented above that JR is most likely suffering from
one of the rarest forms of CJD, the Heidenhain
variant, first described by Heidenhain in 1929 [30].
These patients typically present at an early stage
with hemianopsia, but without pyramidal symptoms
or lesion detectable by neuroimaging [45], followed
by progressive metamorphopsia [8], visual
hallucinations, and diminished visual acuity,
culminating in cortical blindness without remarkable
ocular pathology. Furthermore, all reported cases of
the Heidenhain variant to date have been positive
for the 14-3-3 marker protein in CSF. To this point,
JR’s profile fits these diagnostic criteria precisely.
However, decline in this variant is rapid and
decease occurs within 5-7 months of onset [8],
whereas JR, after a rapid decline in December 2000
- January 2001, has survived for almost a year. The
absence of either genetic or environmental factors
clearly predisposing JR to CJD is also puzzling. If
indeed this patient has Hv-CJD, then there are some
very serious and very important questions to be
asked about the course of the disease and the mode
of transmission. It would be premature at this point,
however, to address these issues without
neuropathological results. 
The evolution of hallucinations in this case is
particularly interesting. The process that led in JR’s
case from visual disorders to hallucinations can be
conceived as a series of statements:
– I see black spots on the wall.
– The black spots look like bugs.
– The black spots are bugs.
– There are black bugs climbing up the wall.
In other words, the patient began by describing the
visual phenomenon, being fully aware that the
spots she was seeing were not really there on the
wall (which in fact prompted her to seek medical
attention). Later she used an analogy to describe
the appearance of these black spots, but in time
the analogy lost its metaphorical force and became
a statement of fact. At that point the patient lost all
criticism and interpreted what she was seeing
literally, using the category suggested by the
metaphor. Under the influence of anxiety and
dementia, producing a loss of criticism, the visual
disorders were gradually transformed into
psychotic disturbances.
CONCLUSIONS
1. The case here described, which exhibits all the
clinical features of Creutzfeldt-Jakob Disease, is
remarkable for agraphia as the first presenting
symptom, the absence of obvious genetic or
environmental risk factors, and the somewhat
protracted course. 
2. The clinical picture is largely consistent with the
Heidenhain variant of CJD, except for the
patient’s survival for more than a year after first
presentation. The symptomatology suggests that
the initial point of attack for the spongiform
encephalopathy was in the right occipital lobe.
Figure 5. Changes in overall intelligence (WAIS-R) in patient JR
between early October and late December of 2000.
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3. The mode of transmission of CJD in JR’s case is
unclear, especially in the absence of any genetic
or environmental factors known to be conducive
to contracting CJD.
4. In cases of vision disturbances without ocular
pathology, when other neurological causes have
been ruled out, the possibility of Hv-CJD should
be considered.
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